Standout Papers

Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with ... 1997 2026 2006 2016 954
  1. Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors (1997)
    Moosa Mohammadi, Gerald McMahon et al. Science
  2. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema (2000)
    Yasunori Kasahara, Rubin M. Tuder et al. Journal of Clinical Investigation
  3. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension (2001)
    Laimute Taraseviciene‐Stewart, Yasunori Kasahara et al. The FASEB Journal
  4. Vemurafenib: the first drug approved for BRAF-mutant cancer (2012)
    Gideon Bollag, James Tsai et al. Nature Reviews Drug Discovery

Immediate Impact

12 by Nobel laureates 24 from Science/Nature 67 standout
Sub-graph 1 of 20

Citing Papers

SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
2015 Standout
1 intermediate paper

Works of Peter Hirth being referenced

Vemurafenib: the first drug approved for BRAF-mutant cancer
2012 Standout
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
2000 Standout

Author Peers

Author Last Decade Papers Cites
Peter Hirth 2068 119 576 1286 35 4.1k
Mary A. Napier 1815 221 649 337 44 3.8k
Shelia M. Violette 2106 25 1204 1183 69 5.1k
Hideki Yokoyama 2885 64 1071 1275 84 5.1k
Daniela S. Krause 2708 42 1543 587 73 5.9k
Judy Pawling 4407 14 768 359 37 5.7k
Chryso Kanthou 1710 82 607 261 61 3.4k
Brunhilde Felding‐Habermann 2366 62 1939 810 43 5.4k
F. Michael Yakes 3406 40 2256 1088 20 5.8k
Benjamin D. Hopkins 2872 26 943 553 41 4.3k
Karen Bernard 1117 16 229 1652 29 3.1k

All Works

Loading papers...

Rankless by CCL
2026